Effect of sesame supplementation on body composition and lipid profile in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
- PMID: 38316576
- DOI: 10.1016/j.numecd.2024.01.020
Effect of sesame supplementation on body composition and lipid profile in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
Abstract
Aims: The aim of this study was to conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) that evaluated the impact of sesame supplementation on body weight (BW), body mass index (BMI), triglycerides (TGs), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), and high-density lipoprotein-cholesterol (HDL-C) in patients with type 2 diabetes mellitus (T2DM).
Data synthesis: PubMed, Scopus, ISI Web of Science, and Embase were searched without any restrictions until September 2023.Only RCTs reporting the effects of sesame supplementation on body composition and lipid profiles were included, while observational studies and animal models were excluded. The methodological quality of the studies was assessed using the Cochrane risk of bias tool. Out of 997 studies identified, 10 were included in the systematic review and meta-analysis. Our meta-analysis suggested a significant association between sesame supplementation and reduction in TG (weighted mean difference (WMD): -37.61 mg/dl, 95 % CI: -61.48, 13.73), TC (WMD: -32.69 mg/dl, 95 % CI: -47.26, 18.12), and LDL-C (WMD: -28.72 mg/dl, 95 % CI: -44.68, 12.76). However, our meta-analysis indicated that the supplementary intake of sesame had no significant effect on HDL-C, BW, and BMI in patients with T2DM.
Conclusions: This study showed that sesame consumption significantly lowered TG, TC, and LDL-C levels, which may have contributed to the improvement of clinical symptoms in T2DM. However, given the limited number of trials included in the analysis, additional large-scale studies are needed to confirm the effects of sesame consumption on the lipid profile and body composition in patients with T2DM.
Prospero code: CRD42023460630.
Keywords: Body composition; Lipid profile; Meta-analysis; Sesame; Triglycerides.
Copyright © 2024 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that there are no conflicts of interest.
Similar articles
-
Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.Biol Trace Elem Res. 2024 Nov;202(11):4877-4892. doi: 10.1007/s12011-024-04059-x. Epub 2024 Jan 15. Biol Trace Elem Res. 2024. PMID: 38224402
-
Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1260-1271. doi: 10.1016/j.numecd.2020.03.021. Epub 2020 Mar 28. Nutr Metab Cardiovasc Dis. 2020. PMID: 32451277
-
Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1465-1475. doi: 10.1016/j.numecd.2020.05.015. Epub 2020 Jun 3. Nutr Metab Cardiovasc Dis. 2020. PMID: 32675010
-
Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials.Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1151-1167. doi: 10.1016/j.numecd.2019.07.012. Epub 2019 Jul 24. Nutr Metab Cardiovasc Dis. 2019. PMID: 31561944
-
The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: A meta-analysis of randomized controlled trials.Pharmacol Res. 2020 Nov;161:105113. doi: 10.1016/j.phrs.2020.105113. Epub 2020 Aug 2. Pharmacol Res. 2020. PMID: 32755613
Cited by
-
Clinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.Nutr Metab (Lond). 2025 Mar 11;22(1):22. doi: 10.1186/s12986-025-00910-7. Nutr Metab (Lond). 2025. PMID: 40069782 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous